-
Spatial Transcriptomics Uncovers Tumor Microenvironment-Based Subtypes in Invasive Lobular Carcinoma
Study
EGAS50000001001
-
ST lobular manuscript dataset
Dataset
EGAD50000001467
-
PD1-targeted delivery of an IL-2 variant induces a multifaceted anti-tumoral T cell response in human lung cancer
Study
EGAS50000000396
-
p200503_fn2
Study
EGAS50000001121
-
RNA-Sequencing data of Fusobacterium nucleatum treated CAFs and HT-29 tumor spheroid exposed to Fusobacterium nucleatum treated CAFs conditioned medium.
Dataset
EGAD50000001614
-
Batches 1-3 prostatectomy analysis
Dataset
EGAD00001001116
-
The Oral Microbiome and Head and Neck Cancer
Study
phs004018
-
Oncogenome of Kaposi Sarcoma
Study
phs003897
-
PE-CGS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in Cancer Genomic Characterization Studies
Study
phs003985
-
Collagen XVII Promotes Pancreatic Cancer Through Regulation of PIK3R5
Study
phs003641
-
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia
Study
EGAS50000001075
-
Multi-omics analysis of an individual with multiple pancreatic neuroendocrine tumours (panNETs)
Study
EGAS00001006722
-
Dataset with WGBS data of CRC and colon tissue
Dataset
EGAD50000000772
-
Whole-genome and transcriptome versus panel sequencing in precision oncology: A translational-clinical comparison
Study
EGAS50000000431
-
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Study
EGAS50000000932
-
Germline WES of serrated polyposis syndrome
Study
EGAS50000000765
-
ACUITI
Study
EGAS50000000962
-
Evaluation of the ERa binding region activity in breast and endometrial cancer
Study
EGAS50000000009
-
STARR-seq of ERa binding sites in MCF7 and Ishikawa cell lines
Dataset
EGAD50000000015
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - WGS
Study
EGAS50000001082
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - Targeted
Study
EGAS50000001081
-
Enhancer profiling to identify identifies epigenetic markers of endocrine resistance in metastatic castration resistant prostate cancer patients
Study
EGAS00001006161
-
Multi-omic analyses from a randomized phase II study of epigenetic priming followed by nivolumab in previously treated metastatic non-small cell lung cancer
Study
EGAS50000000913
-
Study of biomarkers implicated in radio-immunotherapy response in metastatic cancer
Study
EGAS50000001149
-
Multi-omic dataset utilized in the analysis of a phase II study of epigenetic priming followed by nivolumab in lung cancer
Dataset
EGAD50000001336